Torrent Pharma Complete Fundamental Analysis
Originally published: 04/05/2020 09:26
Publication number: ELQ-82413-1
View all versions & Certificate
certified

Torrent Pharma Complete Fundamental Analysis

Fundamental Analysis in Microsoft Excel of Steel Authority of Torrent Pharma Shares

Description
Torrent Pharma is the flagship company of the Torrent Group which operates mainly in the healthcare and utility industry. The company is a market leader in the therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI) and women healthcare (WHC). Torrent Pharma was a pioneer in initiating the concept of niche marketing in India and this is still a core business driver for the company. The company has a presence in over 40+ countries in the world.

The Model covers all the major fundamental aspects of Torrent Pharma over the ten year period. The model is easy to edit and update for the future years as well. It includes:
1. Growth Ratios
2. Profitability Ratios
3. Cash Flow Ratios
4. Liquidity and Solvency Ratios
5. Efficiency Ratios
6. Valuation Ratios
7. ROE (Du Pont Analysis)
8. Common Size analysis
9. Enterprise Valuation
10. Financial Strength Analysis

Further Qualitative analysis is also done considering these factors and ratings have been assigned. The complete detailed analysis is in the word document along with the Excel model.

More about Torrent Pharma:

The pharma industry is dominated either by the scale of operations in case of generic medicines or by patents of speciality drug formulations. Torrent Pharma has been able to take lead in both the ways by in house R&D and acquisition. The company has a long history of successful acquisition which created business synergies.

Torrent Pharma started international acquisitions in 2005 with 90-year-old Heumann brand from Pfizer to enter the German market. Later on, purchased ANDA of Minocycline from Ranbaxy in 2015. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceutical business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, women healthcare brands from Novartis strengthened Torrent Pharma's position in the Indian Pharma market. In January 2018, Torrent also acquired Bio-Pharm (BPI) generic pharmaceuticals and OTC Company, based in Pennsylvania, USA, which also included a US FDA registered manufacturing facility. This has made the company to grow across borders.

This Best Practice includes
1 Microsoft Excel Model +1 Microsoft Word Document

Acquire nonprofit license for $3.50

Add to cart

Add to bookmarks

Discuss

Further information

The aim is to provide a thorough outlook into the company's financial position. This will help the students in projects and learning fundamental analysis. This can also be used by Investors who are looking to do their own due diligence before investing in the Indian Stock Markets.

Equity Research, Fundamental Analysis, Valuation, Long Term Investing


0.0 / 5 (0 votes)

please wait...